Qingyong Li

2.0k total citations
66 papers, 1.6k citations indexed

About

Qingyong Li is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Qingyong Li has authored 66 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 22 papers in Oncology and 12 papers in Organic Chemistry. Recurrent topics in Qingyong Li's work include Cancer therapeutics and mechanisms (30 papers), Drug Transport and Resistance Mechanisms (13 papers) and Synthesis and biological activity (6 papers). Qingyong Li is often cited by papers focused on Cancer therapeutics and mechanisms (30 papers), Drug Transport and Resistance Mechanisms (13 papers) and Synthesis and biological activity (6 papers). Qingyong Li collaborates with scholars based in China, United States and United Kingdom. Qingyong Li's co-authors include Yuangang Zu, Liping Yao, Fengzhi Li, Xiang Ling, Jialin Xu, Tao Jiang, Wenchao Wang, Jiaoyan Ren, Yujuan Li and Xiaoyan Kang and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Qingyong Li

63 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingyong Li China 21 843 313 257 192 167 66 1.6k
Bo Yang China 22 650 0.8× 293 0.9× 560 2.2× 308 1.6× 187 1.1× 136 1.9k
Amareshwar T.K. Singh United States 17 1.2k 1.5× 458 1.5× 208 0.8× 186 1.0× 150 0.9× 32 2.3k
Arvind Negi India 21 711 0.8× 134 0.4× 408 1.6× 189 1.0× 107 0.6× 78 1.6k
Rong Liu China 22 794 0.9× 185 0.6× 288 1.1× 307 1.6× 235 1.4× 79 1.8k
Qian Lei China 29 1.1k 1.3× 249 0.8× 320 1.2× 59 0.3× 85 0.5× 85 2.0k
Jianzhang Wu China 27 1.1k 1.4× 186 0.6× 654 2.5× 65 0.3× 183 1.1× 116 2.3k
Haiyang Yu China 25 1.0k 1.2× 166 0.5× 218 0.8× 109 0.6× 64 0.4× 94 1.9k
Yuan Zhu China 25 482 0.6× 101 0.3× 135 0.5× 299 1.6× 130 0.8× 57 1.7k
Jianfang Feng China 27 785 0.9× 145 0.5× 106 0.4× 484 2.5× 223 1.3× 68 1.9k
Yan Xie China 28 710 0.8× 215 0.7× 246 1.0× 502 2.6× 393 2.4× 60 2.5k

Countries citing papers authored by Qingyong Li

Since Specialization
Citations

This map shows the geographic impact of Qingyong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyong Li more than expected).

Fields of papers citing papers by Qingyong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyong Li. The network helps show where Qingyong Li may publish in the future.

Co-authorship network of co-authors of Qingyong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyong Li. A scholar is included among the top collaborators of Qingyong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyong Li. Qingyong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Wenchao, Lei Li, Wei‐Xue Li, et al.. (2024). Design, synthesis and investigation of biological activity and mechanism of fluoroaryl-substituted derivatives at the FL118 position 7. European Journal of Medicinal Chemistry. 283. 117143–117143.
2.
Wang, Wenchao, et al.. (2024). Effects of Different Extraction Methods on Biological Activities of Pearl Powder Extracts. Chemistry Africa. 7(7). 3647–3658. 1 indexed citations
3.
Sun, Xuanrong, et al.. (2024). T7 Peptide-modified macrophage membrane-coated nanoplatform for enhanced glioma treatment. European Journal of Pharmaceutics and Biopharmaceutics. 204. 114527–114527. 4 indexed citations
4.
Wang, Wenchao, Xiang Ling, Zhikun Yang, et al.. (2023). Structure–Activity Relationship of FL118 Platform Position 7 Versus Position 9-Derived Compounds and Their Mechanism of Action and Antitumor Activity. Journal of Medicinal Chemistry. 66(24). 16888–16916. 3 indexed citations
5.
Yang, Zhikun, Xue Yang, Yasheng Li, et al.. (2023). Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell. European Journal of Medicinal Chemistry. 248. 115092–115092. 20 indexed citations
6.
Wang, Yi, Xiangli Zhang, Yanlei Yu, et al.. (2022). Investigation of the Uptake and Transport of Two Novel Camptothecin Derivatives in Caco-2 Cell Monolayers. Molecules. 27(12). 3669–3669. 6 indexed citations
7.
Tian, Bin, et al.. (2022). Effect of the combination of cognitive behavioral therapy and oral paroxetine hydrochloride in patients with post-stroke depression. Tropical Journal of Pharmaceutical Research. 21(9). 1993–2000. 1 indexed citations
8.
Zhou, Yuqin, et al.. (2021). Cellular Uptake and Transport Characteristics of FL118 Derivatives in Caco-2 Cell Monolayers. Chemical and Pharmaceutical Bulletin. 69(11). 1054–1060. 11 indexed citations
9.
Liu, Yang, Xiaoling Lin, Qingyong Li, et al.. (2019). Identification of two novel peptides with antioxidant activity and their potential in inhibiting amyloid-β aggregation in vitro. Food & Function. 10(2). 1191–1202. 12 indexed citations
11.
Li, Qingyong, Xiaoyan Kang, Yujuan Li, et al.. (2017). Moderation of hyperuricemia in rats via consuming walnut protein hydrolysate diet and identification of new antihyperuricemic peptides. Food & Function. 9(1). 107–116. 94 indexed citations
12.
Xu, Jialin, Yunfeng Liu, Jianxing Zhang, et al.. (2017). Optimization of hydrogel containing toluidine blue O for photodynamic therapy by response surface methodology. Journal of Photochemistry and Photobiology B Biology. 173. 389–396. 18 indexed citations
13.
Li, Qingyong, Wenchao Wang, Yuhui Liu, et al.. (2014). The biological characteristics of a novel camptothecin–artesunate conjugate. Bioorganic & Medicinal Chemistry Letters. 25(1). 148–152. 17 indexed citations
14.
Li, Qingyong. (2013). Research progress of bile acid as a drug carrier. Zhongguo xin yao zazhi. 1 indexed citations
15.
16.
Cao, Jianguo, et al.. (2006). The seasonal dynamics of the content of syringin and total flavonoid in different parts of Acanthopanax senticosus. Chinese Bulletin of Botany. 23(3). 269–274. 2 indexed citations
17.
Zu, Yuangang, et al.. (2006). Rapid separation of four main taxoids in Taxus species by a combined LLP‐SPE‐HPLC (PAD) procedure. Journal of Separation Science. 29(9). 1237–1244. 30 indexed citations
18.
Li, Qingyong, et al.. (2006). Review Camptothecin: Current Perspectives. Current Medicinal Chemistry. 13(17). 2021–2039. 224 indexed citations
19.
Li, Qingyong, Ying Zhang, Liping Yao, et al.. (2005). [Synthesis of camptothecin glycosides by phase transfer-catalysis and its inhibitory activity against topo I].. PubMed. 40(12). 1116–21. 2 indexed citations
20.
Li, Qingyong, et al.. (2004). [Synthesis and antitumor activities of 10-hydroxy camptothecin derivatives].. PubMed. 39(7). 521–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026